Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Minority Interest (2016 - 2026)

Lexaria Bioscience's Minority Interest history spans 11 years, with the latest figure at -$392191.0 for Q1 2026.

  • Quarterly results put Minority Interest at -$392191.0 for Q1 2026, down 2.12% from a year ago — trailing twelve months through Feb 2026 was -$392191.0 (down 2.12% YoY), and the annual figure for FY2025 was -$386942.0, down 2.54%.
  • Minority Interest for Q1 2026 was -$392191.0 at Lexaria Bioscience, down from -$389438.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of -$235307.0 in Q1 2022 to a low of -$392191.0 in Q1 2026.
  • The 5-year median for Minority Interest is -$372949.0 (2024), against an average of -$354526.0.
  • The sharpest move saw Minority Interest tumbled 249.26% in 2022, then fell 2.12% in 2026.
  • Year by year, Minority Interest stood at -$329776.0 in 2022, then dropped by 12.12% to -$369755.0 in 2023, then fell by 2.85% to -$380278.0 in 2024, then dropped by 2.41% to -$389438.0 in 2025, then decreased by 0.71% to -$392191.0 in 2026.
  • According to Business Quant data, Minority Interest over the past three periods came in at -$392191.0, -$389438.0, and -$386942.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.